Concepedia

Julie D. Seroogy

JD

7

Publications

351

Citations

7

H-Index

2004

Active since

Affiliations

Theravance Biopharma (United States)(Current)

Institute for Clinical Pharmacodynamics (United States)

Allogene Therapeutics (United States)

Julie D. Seroogy is an author at Theravance Biopharma (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

2004–2019

7

Publications

7

Pharmacokinetics, Serum Inhibitory and Bactericidal Activity, and Safety of Telavancin in Healthy Subjects

J P Shaw, Julie D. Seroogy, Koné Kaniga et al. · Antimicrobial Agents and Chemotherapy · 2004 · 146 citations · Full text

Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety

Frederick Cohen, James B. Aggen, Logan D. Andrews et al. · ChemMedChem · 2019 · 75 citations

, , +19

Tissue Penetration of Telavancin after Intravenous Administration in Healthy Subjects

Heather K. Sun, Kenneth L. Duchin, Charles H. Nightingale et al. · Antimicrobial Agents and Chemotherapy · 2006 · 63 citations · Full text

, , +7

Population Pharmacokinetic Analyses for Plazomicin Using Pooled Data from Phase 1, 2, and 3 Clinical Studies

Michael Trang, Julie D. Seroogy, Scott A. Van Wart et al. · Antimicrobial Agents and Chemotherapy · 2019 · 24 citations · Full text

Telavancin and Hydroxy Propyl-β-Cyclodextrin Clearance during Continuous Renal Replacement Therapy: An <i>in vitro</i> Study

Jignesh H. Patel, Mariann D. Churchwell, Julie D. Seroogy et al. · The International Journal of Artificial Organs · 2009 · 18 citations

Rows per page

1–5 of 7